Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial
- 1 July 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9173) , 116-119
- https://doi.org/10.1016/s0140-6736(98)10448-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in South IndiaPublished by Elsevier ,2004
- Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in AfricaRespiratory Medicine, 1995
- HIV-associated tuberculosis in developing countries: epidemiology and strategies for preventionTubercle and Lung Disease, 1992
- Immunotherapy for drug-resistant tuberculosisThe Lancet, 1992
- The mystery of the mycobacterial ‘persistor’Tubercle and Lung Disease, 1992
- Pulmonary Tuberculosis in Kigali, Rwanda: Impact of Human Immunodeficiency Virus Infection on Clinical and Radiographic PresentationAmerican Review of Respiratory Disease, 1992
- Understanding the chemotherapy of tuberculosis—current problemsJournal of Antimicrobial Chemotherapy, 1992
- Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccaeTubercle, 1990
- Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosisVaccine, 1990